- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Biotechnology R&D intensity in enterprise sector by country 2017
Biotechnology R&D intensity in enterprise sector by country 2017
Biotech R&D intensity in the enterprise sector in selected countries as of 2017
by Matej Mikulic,
last edited
Dec 11, 2018
This statistic shows the research and development intensity of biotechnology companies in selected countries for 2017 (or latest year available - 2015, 2016). As of that year, U.S. biotech R&D in the enterprise sector was around 0.38 percent of the total industry value added.
Biotech R&D intensity in the enterprise sector in selected countries as of 2017
Loading statistic...
Expand statistic
| Biotech R&D as a percent of industry value added | |
|---|---|
| Belgium | 0.44% |
| United States | 0.38% |
| France | 0.23% |
| Sweden | 0.17% |
| Slovenia | 0.15% |
| Estonia | 0.12% |
| South Korea | 0.12% |
| Norway | 0.11% |
| Spain | 0.09% |
| Lithuania | 0.09% |
| Czech Republic | 0.07% |
| Austria | 0.07% |
| Finland | 0.06% |
| Italy | 0.05% |
| Germany | 0.05% |
| Portugal | 0.02% |
| Poland | 0.02% |
| Russian Federation | 0.01% |
| Biotech R&D as a percent of industry value added | |
|---|---|
| Belgium | 0.44% |
| United States | 0.38% |
| France | 0.23% |
| Sweden | 0.17% |
| Slovenia | 0.15% |
| Estonia | 0.12% |
| South Korea | 0.12% |
| Norway | 0.11% |
| Spain | 0.09% |
| Lithuania | 0.09% |
| Czech Republic | 0.07% |
| Austria | 0.07% |
| Finland | 0.06% |
| Italy | 0.05% |
| Germany | 0.05% |
| Portugal | 0.02% |
| Poland | 0.02% |
| Russian Federation | 0.01% |
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Dec 11, 2018
This statistic shows the research and development intensity of biotechnology companies in selected countries for 2017 (or latest year available - 2015, 2016). As of that year, U.S. biotech R&D in the enterprise sector was around 0.38 percent of the total industry value added.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- October 2018
- Region
- Worldwide, OECD
- Survey time period
- 2015 to 2017
- Supplementary notes
-
* Or latest year available (2015, 2016).
For the Russian Federation, a proxy indicator is used: R&D expenditure in Life Sciences (before 2011 - Living Systems), which include bioengineering, biocatalysis, biosynthesis and biosensor technologies, biomedical and veterinary technologies, genomics and pharmaco-genetics, living cell technologies.
For Sweden, firms with 10 or more employees only.
For the United States, firms with 5 or more employees only.
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- October 2018
More information
- Region
- Worldwide, OECD
- Survey time period
- 2015 to 2017
- Supplementary notes
-
* Or latest year available (2015, 2016).
For the Russian Federation, a proxy indicator is used: R&D expenditure in Life Sciences (before 2011 - Living Systems), which include bioengineering, biocatalysis, biosynthesis and biosensor technologies, biomedical and veterinary technologies, genomics and pharmaco-genetics, living cell technologies.
For Sweden, firms with 10 or more employees only.
For the United States, firms with 5 or more employees only.
Other statistics on the topic
+Pharmaceutical Products & Market
Revenues of biopharmaceutical companies in Germany from 2007 to 2017
+Pharmaceutical Products & Market
Private and listed biotechnology companies in Germany from 2009 to 2018
+Pharmaceutical Products & Market
Fields of occupation in industrial biotechnology companies in Germany 2012-2016
Pharmaceutical Products & Market
Biotechnology companies in Germany from 2006 to 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Biotechnology in Germany"
- Overview
The most important statistics
- Number of biotechnology companies in Germany from 2006 to 2017Biotechnology companies in Germany from 2006 to 2017
- Number of private and listed biotechnology companies in Germany from 2009 to 2018Private and listed biotechnology companies in Germany from 2009 to 2018
- Number of biotechnology companies in Germany from 2013 to 2017, by stateBiotechnology companies in Germany from 2013 to 2017 by state
- Number of active biotechnological research facilities in Germany from 2008 to 2012Biotechnological research facilities in Germany from 2008 to 2012
- Share of occupation fields in biotechnology companies in Germany from 2011 to 2016Fields of occupation in biotechnology companies in Germany from 2011 to 2016
- Number of medical biotechnology companies in Germany from 2012 to 2016, by occupation fieldFields of occupation in medical biotechnology companies in Germany from 2012 to 2016
- Number of industrial biotechnology companies in Germany from 2012 to 2016, by occupation fieldFields of occupation in industrial biotechnology companies in Germany 2012-2016
- Leading dedicated biotechnology companies in Germany as of 2016, by number of employeesGerman biotechnology companies by employees as of 2016
- Biopharmaceutical market
The most important statistics
- Development of revenues of biopharmaceutical companies compared to the total pharmaceutical market in Germany from 2008 to 2017Revenue development of biopharmaceuticals in Germany from 2008 to 2017
- Development of revenues in the biotech industry in Germany from 1999 to 2018 (in million euros)Revenue development in the German biotech industry 1999-2018
- Development of revenues in biotechnology companies in Germany from 2007 to 2017*Revenue development in biotechnology companies in Germany from 2007 to 2017
- Distribution of revenues of biopharmaceutical companies compared to the total pharmaceutical market in Germany from 2007 to 2017 (in billion euros)Revenues of biopharmaceutical companies in Germany from 2007 to 2017
- Number of approvals of pharmaceuticals in Germany from 2013 to 2017, by drug typeBiopharmaceutical approvals in Germany from 2013 to 2017, by drug type
- Distribution of revenues on the statutory health insurance market of biopharmaceuticals in Germany as of 2014, by patent status (in billion euros)Biopharmaceutical revenue - statutory health insurance market Germany 2014
- Revenues of pharmaceuticals in Germany in 2017, by field of application (in million euros)*Biopharmaceutical revenues in Germany in 2017 by application field
- Share of biopharmaceutical revenues in Germany as of 2017, by field of applicationBiopharmaceutical revenue share in Germany 2017 by application field
- Research and components
The most important statistics
- Expenditure for research and development in listed and private biotechnology companies in Germany from 2009 to 2018 (in million euros)R&D expenditure of biotechnology companies in Germany from 2009 to 2018
- Development of R&D spending in dedicated biotechnology companies in Germany from 2007 to 2017*R&D spending development in biotechnology companies in Germany from 2007 to 2017
- Number of new pharmaceutical registrations in Germany from 2000 to 2017Biopharmaceuticals new registrations in Germany 2000-2017
- Share of new pharmaceutical registrations in Germany from 2000 to 2017Biopharmaceuticals: new registrations share in Germany 2000-2017
- Number of biopharmaceutical drugs in development in Germany from 2008 to 2017, by phaseBiopharmaceutical drugs in Germany 2008-2017 by stage of development
- Number of drugs in development in biotechnology companies in Germany from 2011 to 2016Drugs developed in biotechnology companies in Germany from 2011 to 2016
- Number of biopharmaceuticals in clinical development in Germany as of 2011, by drugBiopharmaceuticals in clinical development in Germany 2011, by drug
- Number of active biopharmaceutical ingredients in development in Germany as of 2017, by field of indicationBiopharmaceutical pipelines in Germany 2017 by field of indication
- Funding
The most important statistics
- Funding sources of dedicated biotechnology companies in Germany from 2005 to 2017 (in million euros)Funding sources of biotechnology companies in Germany from 2005 to 2017
- Distribution of biotechnology companies capital flow in Europe from 2008 to 2018 (in billion euros)Capital inflow of biotechnology companies in Europe from 2008 to 2018
- Distribution of biotechnology companies capital flow in Germany from 2005 to 2018 (in million euros)Capital inflow in biotechnology companies in Germany from 2005 to 2018
- Budget of biotechnological research institutions in Germany from 2008 to 2012 (in million euros)Biotechnological research institutions budget in Germany from 2008 to 2012
- Losses of listed and private biotech companies in Germany from 2009 to 2014 (in million euros)Losses of listed and private biotech companies Germany 2014
- Occupation
The most important statistics
- Number of employees in the biotechnology industry in Germany from 2008 to 2018Employees in German biotechnology companies from 2008 to 2018
- Number of employees in biotechnology companies in Germany from 2013 to 2017, by stateEmployees in biotechnology companies in Germany from 2013 to 2017 by state
- Number of employees in biotechnological research institutions in Germany from 2008 to 2012Employees in biotechnological research institutions in Germany from 2008 to 2012
- Number of employees in the medical biotechnology industry in Germany from 2010 to 2017Employees in the medical biotechnology industry in Germany from 2010 to 2017
- Size of biotechnology companies in Germany from 2005 to 2009, by number of employeesBiotechnology companies size in Germany from 2005 to 2009 by employees
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Dedicated biotechnology company number comparison by select country 2017
- Biotechnology R&D expenditure in selected countries 2017
- Biotech company R&D expenditure by country and by application 2014
- Dedicated biotechnology companies by country and application 2014
- German biotechnology companies by employees 2017
- Biotechnology R&D expenditure as percent of BERD in select countries 2017
- Biotech company R&D expenditure selected countries by firm size 2014
- Percentage of country share in biotechnology patents 2014
- Italy: number of biotech companies in the pharma sector 2014-2017
- Research & development expenditure of biotechnology companies in Germany 2008-2017
- Biotech industry growth rates in Australia compared to worldwide 2016
- Global biotechnology revenue by region 2012
- Global biotechnology market share by region 2012
- Share of Australian biotech companies by state 2015
- Key figures for Australian public biotech companies 2015
- Gilead Sciences' spending on research and development 2008-2018
- Genentech product sales
- Boehringer Ingelheim's total revenue 2007-2018
- Boehringer Ingelheim's R&D expenditure as a percentage of revenue 2004-2018
- Boehringer Ingelheim's income after taxes 2005-2018
Statistics on "Biotechnology in Germany"
- Number of biotechnology companies in Germany from 2006 to 2017
- Number of private and listed biotechnology companies in Germany from 2009 to 2018
- Number of biotechnology companies in Germany from 2013 to 2017, by state
- Number of active biotechnological research facilities in Germany from 2008 to 2012
- Share of occupation fields in biotechnology companies in Germany from 2011 to 2016
- Number of medical biotechnology companies in Germany from 2012 to 2016, by occupation field
- Number of industrial biotechnology companies in Germany from 2012 to 2016, by occupation field
- Leading dedicated biotechnology companies in Germany as of 2016, by number of employees
- Development of revenues of biopharmaceutical companies compared to the total pharmaceutical market in Germany from 2008 to 2017
- Development of revenues in the biotech industry in Germany from 1999 to 2018 (in million euros)
- Development of revenues in biotechnology companies in Germany from 2007 to 2017*
- Distribution of revenues of biopharmaceutical companies compared to the total pharmaceutical market in Germany from 2007 to 2017 (in billion euros)
- Number of approvals of pharmaceuticals in Germany from 2013 to 2017, by drug type
- Distribution of revenues on the statutory health insurance market of biopharmaceuticals in Germany as of 2014, by patent status (in billion euros)
- Revenues of pharmaceuticals in Germany in 2017, by field of application (in million euros)*
- Share of biopharmaceutical revenues in Germany as of 2017, by field of application
- Share of biopharmaceutical revenues in Germany from 2009 to 2013, by therapeutic area
- Expenditure for research and development in listed and private biotechnology companies in Germany from 2009 to 2018 (in million euros)
- Development of R&D spending in dedicated biotechnology companies in Germany from 2007 to 2017*
- Number of new pharmaceutical registrations in Germany from 2000 to 2017
- Share of new pharmaceutical registrations in Germany from 2000 to 2017
- Number of biopharmaceutical drugs in development in Germany from 2008 to 2017, by phase
- Number of drugs in development in biotechnology companies in Germany from 2011 to 2016
- Number of biopharmaceuticals in clinical development in Germany as of 2011, by drug
- Number of active biopharmaceutical ingredients in development in Germany as of 2017, by field of indication
- Share of therapy fields in the clinical and preclinical development pipeline in biotech companies in Germany as of 2013
- Number of active biopharmaceutical ingredients in the development pipeline in Germany as of 2017, by phase and patent status
- Funding sources of dedicated biotechnology companies in Germany from 2005 to 2017 (in million euros)
- Distribution of biotechnology companies capital flow in Europe from 2008 to 2018 (in billion euros)
- Distribution of biotechnology companies capital flow in Germany from 2005 to 2018 (in million euros)
- Budget of biotechnological research institutions in Germany from 2008 to 2012 (in million euros)
- Losses of listed and private biotech companies in Germany from 2009 to 2014 (in million euros)
- Number of employees in the biotechnology industry in Germany from 2008 to 2018
- Number of employees in biotechnology companies in Germany from 2013 to 2017, by state
- Number of employees in biotechnological research institutions in Germany from 2008 to 2012
- Number of employees in the medical biotechnology industry in Germany from 2010 to 2017
- Size of biotechnology companies in Germany from 2005 to 2009, by number of employees
- Number of dedicated biotechnology companies in select OECD countries as of 2017*
- Biotech research and development expenditure in selected countries as of 2017 (in million U.S. dollars)*
- Percentage of R&D expenditure by biotech companies in selected countries in 2014, by application*
- Percentage of dedicated biotech companies in selected countries in 2014, by application*
- Leading German dedicated biotechnology companies by number of employees worldwide in 2017
- Biotech R&D expenditure as a percent of BERD in selected countries as of 2017*
- Percentage of biotech R&D expenditure in selected countries in 2014, by company size*
- Distribution of biotechnology patents filed in 2014, by country*
- Number of biotech companies in the pharmaceutical sector in Italy in selected years from 2014 to 2017
- Annual research and development expenditure in biotechnology companies in Germany from 2008 to 2017* (in billion euros)
- Selected biotech industry growth rates in Australia compared to the world as of 2016
- Global biotech revenue by region in 2012 (in million U.S. dollars)*
- Percentage of global biotech market by region in 2012
- Distribution of Australian biotech establishments in 2015, by state
- Key figures for Australian public biotech companies as of 2015
- Gilead Sciences' spending on research and development from 2008 to 2018 (in million U.S. dollars)
- Product sales of biotech company Genentech from 2006 to 2008 (in million U.S. dollars)
- Boehringer Ingelheim's total revenue from 2007 to 2018 (in million euros)
- Boehringer Ingelheim's expenditure on research and development as a percentage of revenue from 2004 to 2018
- Boehringer Ingelheim's income after taxes from 2005 to 2018 (in million euros)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Please log in to access our additional functions
Register in seconds and access exclusive features.
Basic Account
|
Instant Access
Premium Account
| ||
|---|---|---|---|
Our services
Click the question mark for further information | Free |
$49 per month* | |
| Basic statistics | |||
| Premium statistics | |||
|
Graph download
| |||
| Download PDF | |||
|
Excel download
| |||
| Register | Purchase now | ||
*Duration: 12 months, billed annually, single license
Yes, let me download!
...and make my research life easier.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.